We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Union's (EU) industry commissioner, Guenter Verheugen,
has pledged to create a new high-level forum to enhance the competitiveness
of Europe's drug sector.
Following recent reports that China's Health Ministry is to ban hospitals from raising drug prices, the country's powerful National Development and Reform Commission (NDRC) has drafted plans to cut some drug prices by an average of 60%.
Taisho Pharmaceutical announced that it had successfully implemented a zero
emissions plan at its Omiya Factory in Saitama Prefecture by the end of fiscal
2004.
Biovitrum AB and Karolinska Institutet (KI) have signed an agreement implicating
that Biovitrum Biopharmaceuticals on behalf of the Department of Woman and Child
Health shall produce a protein for preclinical research.
Novartis AG and Hyrbidon Inc. have entered into research collaboration and license
agreements for the development and commercialisation of new asthma and allergy
drugs based on Hybridon's IMO technology platform.
Mochida Pharmaceutical announced that it will become a sole distributor of Ortho
777-21 and OrthoM-21, low-dose oral contraceptives (triphasic and monophasic,
respectively) currently co-marketed with Jannssen Pharmaceutical, as of June 1.
Strides Arcolab Ltd on Wednesday inched closer to acquiring up to 60 percent
stake in Venezuelean pharmaceutical and marketing company, Biopharma for a consideration
not exceeding one million dollar.
Amid the ongoing controversy over a vitamin supplier's claims
that such products can be used to effectively treat HIV/AIDS, a senior South
African government source has clarified the official position.